Sandusky, Ohio - Tacrolimus 0.1 percent ointment can treat a subset of patients with granuloma annulare (GA), according to a study conducted at Northern Ohio Dermatology Research in Sandusky, Ohio. The phase IV, open-label, single-center, clinical trial was conducted by Mandi R. Motter, R.N., clinical research coordinator, Thomas E. Fleming, M.D., principal investigator, and colleagues.
FDA implements updated iPLEDGE REMS requirements for isotretinoin, allowing at-home pregnancy testing and reducing prescription and counseling burdens.
Recent dermatology research explores chronic hand eczema prevalence, cancer risk in morphea, pernio, biologic optimization in HS, and melanoma risk prediction.
A pediatric dermatologist explains how CALM count, size, age, and associated findings separate benign spots from neurofibromatosis type 1 and its mimics.